0001978126-23-000001.txt : 20230522 0001978126-23-000001.hdr.sgml : 20230522 20230522152129 ACCESSION NUMBER: 0001978126-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230522 DATE AS OF CHANGE: 20230522 EFFECTIVENESS DATE: 20230522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Convergent Therapeutics, Inc. CENTRAL INDEX KEY: 0001978126 IRS NUMBER: 852703536 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-482306 FILM NUMBER: 23944155 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-710-4289 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001978126 Convergent Therapeutics, Inc. ONE BROADWAY 14TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 617-710-4289 DELAWARE None None Corporation true 2020 Philip Kantoff One Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Alexander Brown One Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Neil Bander One Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Tal Zaks One Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Jake Simson One Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2023-04-27 false true false 0 99170694 29170704 69999990 false 15 0 0 0 false Convergent Therapeutics, Inc. /s/ Philip Kantoff Philip Kantoff CEO 2023-05-22